ADH2 Promoter Variants for Ethanol-Induced Protein Production

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current recombinant protein production systems using Pichia pastoris, such as those employing the AOX1 promoter, require toxic methanol for induction, which poses safety risks and increases purification costs, and do not offer sufficient control over protein production phases, limiting their industrial applicability.

Innovation Solution

Design and integration of enhanced alcohol dehydrogenase 2 (ADH2) gene promoter variants, including PADH2-Cat1, PADH2-Cat2, and PADH2-NucOpt, which utilize ethanol as an inducer, allowing for regulated and high-yield recombinant protein production by optimizing transcription factor binding sites and nucleosome positioning, thereby separating cell growth and protein production phases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If AOX1 promoter is used for recombinant protein production, then protein production capacity is achieved, but toxic methanol is required for induction posing safety risks

Engineering Contradiction:

Improverecombinant protein production capacityVSAvoidtoxicity of methanol inducer

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameter of the inducer from toxic methanol to non-toxic ethanol, while maintaining the inducible functionality of the promoter system. The ADH2 promoter is naturally induced by ethanol in P. pastoris, replacing the harmful methanol-induced AOX1 promoter system.

Inventive Principle:

Principle #35Parameter changes

2Productivity

If conventional promoter systems are used, then protein production is achieved, but control over protein production phases is insufficient

Engineering Contradiction:

Improveprotein productionVSAvoidcontrol over production phases

Core Design Contradiction:

ProductivityVSEase of operation

Solution Approach 1:

The patent implements dynamic control of promoter activity through ethanol induction. The ADH2 promoter allows temporal separation of cell growth phase (without ethanol) and protein production phase (with ethanol), providing dynamic regulation that was insufficient in conventional promoter systems.

Inventive Principle:

Principle #15Dynamics

3Productivity

If ADH2 promoter variants are designed with optimized transcription factor binding sites, then protein production yield is enhanced, but promoter architecture complexity increases

Engineering Contradiction:

Improveprotein production yieldVSAvoidpromoter architecture

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent applies local quality optimization by specifically modifying transcription factor binding sites at critical positions within the ADH2 promoter architecture. Rather than redesigning the entire promoter, targeted mutations at key regulatory elements (such as Cat8 binding sites) enhance expression while maintaining overall promoter structure.

Inventive Principle:

Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ADH2 promoter variants achieve higher protein production yields compared to wild-type ADH2 and AOX1 promoters, enabling safe, efficient, and controlled recombinant protein production using non-toxic ethanol, with PADH2-Cat2 demonstrating significantly higher production capacities, even surpassing the commonly used AOX1 promoter.

Implementation Method 1

The number, quality, functional position of the transcription factor binding sites available on promoter genes, and the transcription factors which bind to these positions and the interaction between them are the fundamental components of the promoter architecture.

Methodology Applied

Scientific EffectTranscription factor binding:

Implementation Method 2

Design and integration of enhanced alcohol dehydrogenase 2 (ADH2) gene promoter variants, including PADH2-Cat1, PADH2-Cat2, and PADH2-NucOpt, which utilize ethanol as an inducer

Methodology Applied

Scientific EffectInduction:

Implementation Method 3

allowing for regulated and high-yield recombinant protein production by optimizing transcription factor binding sites and nucleosome positioning, thereby separating cell growth and protein production phases.

Methodology Applied

Scientific EffectPhase separation:

Data Source

PatentUS12091658B2Alcohol dehydrogenase 2 (ADH2) promoter variants by promoter engineering

Publication Date: 2024.09.17 ORTA DOGU TEKNIK UNIVERSITESI

AI summary

Pichia pastoris alcohol dehydrogenase 2 (ADH2) promoter variants include at least one of the specified modifications on wild-type Pichia pastoris ADH2 promoter (SEQ ID NO: 1). The modification includes one of the following mutations: integration of a Cat8 transcription factor binding site (TFBS), particularly integration of SEQ ID NO: 3 or other gene sequences that show at least 80% similarity with this sequence, at any positions within nucleotides a) 647 to 660; b) 739 to 752; c) 1 to 948; and d) mutations specified with SEQ ID NO: 2 within nucleotides 15 to 848 separately and combinations thereof.